{"id":"https://openalex.org/W7224012107","doi":"https://doi.org/10.4274/tjh.galenos.2026.16046","title":"Predictive Value of the Zhang Scoring System for Imatinib Failure in Chronic Myeloid Leukemia: A Comparative Analysis with Established Prognostic Models","display_name":"Predictive Value of the Zhang Scoring System for Imatinib Failure in Chronic Myeloid Leukemia: A Comparative Analysis with Established Prognostic Models","publication_year":2026,"publication_date":"2026-10-27","ids":{"openalex":"https://openalex.org/W7224012107","doi":"https://doi.org/10.4274/tjh.galenos.2026.16046","pmid":"https://pubmed.ncbi.nlm.nih.gov/42935240"},"language":"en","primary_location":{"id":"doi:10.4274/tjh.galenos.2026.16046","doi":"https://doi.org/10.4274/tjh.galenos.2026.16046","is_oa":true,"landing_page_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","pdf_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","source":{"id":"https://openalex.org/S4210174942","display_name":"Turkish Journal of Hematology","issn_l":"1300-7777","issn":["1300-7777","1308-5263"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-20","russia-white-list-3","tr-dizin"],"host_organization":"https://openalex.org/P4310320331","host_organization_name":"Galenos Yayinevi","host_organization_lineage":["https://openalex.org/P4310320331"],"host_organization_lineage_names":["Galenos Yayinevi"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turkish Journal of Hematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044636344","display_name":"Hakan Oral","orcid":"https://orcid.org/0000-0001-5227-0422","observed_orcids":["https://orcid.org/0000-0001-5227-0422"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Hakan Oral","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5158939911","display_name":"\u00dcmit Yavuz Malkan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u00dcmit Yavuz Malkan","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062340387","display_name":"Elifcan Alada\u011f","orcid":"https://orcid.org/0000-0002-1206-9908","observed_orcids":["https://orcid.org/0000-0002-1206-9908"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Elifcan Alada\u011f Karakulak","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060202631","display_name":"Hal\u00fbk Demiro\u011flu","orcid":"https://orcid.org/0000-0002-6790-8748","observed_orcids":["https://orcid.org/0000-0002-6790-8748","https://orcid.org/0000-0001-9191-3419"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Haluk Demiro\u011flu","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047150136","display_name":"Hakan G\u00f6ker","orcid":"https://orcid.org/0000-0002-1039-7756","observed_orcids":["https://orcid.org/0000-0002-1039-7756"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Hakan G\u00f6ker","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043620809","display_name":"\u0130brahim C. Haznedaro\u011flu","orcid":"https://orcid.org/0000-0001-8028-9462","observed_orcids":["https://orcid.org/0000-0001-8028-9462"]},"institutions":[{"id":"https://openalex.org/I66514158","display_name":"Hacettepe University","ror":"https://ror.org/04kwvgz42","country_code":"TR","type":"education","lineage":["https://openalex.org/I66514158"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u0130brahim Celalettin Haznedaro\u011flu","raw_affiliation_strings":["Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hacettepe University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, T\u00fcrkiye","institution_ids":["https://openalex.org/I66514158"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I66514158"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84462805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.7009999752044678},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.7459999918937683},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.8529999852180481},{"id":"https://openalex.org/keywords/sokal-risk-score","display_name":"Sokal risk score","score":0.8460000157356262},{"id":"https://openalex.org/keywords/eutos-score","display_name":"EUTOS score","score":0.8980000019073486},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/risk-stratification","display_name":"risk stratification","score":0.7820000052452087},{"id":"https://openalex.org/keywords/competing-risks-regression","display_name":"competing risk regression","score":0.5070000290870667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9351999759674072},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.722100019454956},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.6625999808311462},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6341000199317932},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6061999797821045},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5692999958992004},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.5170000195503235},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.49950000643730164},{"id":"https://openalex.org/C2777045944","wikidata":"https://www.wikidata.org/wiki/Q12170198","display_name":"Zh\u00e0ng","level":3,"score":0.4551999866962433},{"id":"https://openalex.org/C2984538763","wikidata":"https://www.wikidata.org/wiki/Q2260590","display_name":"Scoring system","level":2,"score":0.43720000982284546},{"id":"https://openalex.org/C11783203","wikidata":"https://www.wikidata.org/wiki/Q5478027","display_name":"Framingham Risk Score","level":3,"score":0.4253000020980835},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3743000030517578},{"id":"https://openalex.org/C198433322","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value of tests","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.313400000333786},{"id":"https://openalex.org/C97931131","wikidata":"https://www.wikidata.org/wiki/Q5282087","display_name":"Discriminative model","level":2,"score":0.3116999864578247},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.27230000495910645},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.2702000141143799},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25209999084472656}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.4274/tjh.galenos.2026.16046","doi":"https://doi.org/10.4274/tjh.galenos.2026.16046","is_oa":true,"landing_page_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","pdf_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","source":{"id":"https://openalex.org/S4210174942","display_name":"Turkish Journal of Hematology","issn_l":"1300-7777","issn":["1300-7777","1308-5263"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-20","russia-white-list-3","tr-dizin"],"host_organization":"https://openalex.org/P4310320331","host_organization_name":"Galenos Yayinevi","host_organization_lineage":["https://openalex.org/P4310320331"],"host_organization_lineage_names":["Galenos Yayinevi"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turkish Journal of Hematology","raw_type":"journal-article"},{"id":"pmid:42935240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42935240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turkish journal of haematology : official journal of Turkish Society of Haematology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4274/tjh.galenos.2026.16046","doi":"https://doi.org/10.4274/tjh.galenos.2026.16046","is_oa":true,"landing_page_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","pdf_url":"https://doi.org/10.4274/tjh.galenos.2026.16046","source":{"id":"https://openalex.org/S4210174942","display_name":"Turkish Journal of Hematology","issn_l":"1300-7777","issn":["1300-7777","1308-5263"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","medline","poland-20","russia-white-list-3","tr-dizin"],"host_organization":"https://openalex.org/P4310320331","host_organization_name":"Galenos Yayinevi","host_organization_lineage":["https://openalex.org/P4310320331"],"host_organization_lineage_names":["Galenos Yayinevi"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Turkish Journal of Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224012107.pdf","grobid_xml":"https://content.openalex.org/works/W7224012107.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4213211014","https://openalex.org/W3213093338","https://openalex.org/W4386582437","https://openalex.org/W2113387041","https://openalex.org/W4405038443","https://openalex.org/W2469366343","https://openalex.org/W6920944099","https://openalex.org/W4310159147","https://openalex.org/W4361003980","https://openalex.org/W4389232342"],"abstract_inverted_index":{"Objective:":[0],"The":[1],"aim":[2],"of":[3,12,36],"this":[4],"study":[5],"was":[6],"to":[7],"evaluate":[8],"the":[9,13,74,81,85,94,108,135,141,149],"predictive":[10,146],"performance":[11,147],"Zhang":[14,82,125,142],"score":[15,83,143],"in":[16],"comparison":[17],"with":[18,39,73,93,130,134],"other":[19,150],"chronic":[20],"myeloid":[21],"leukemia":[22],"(CML)":[23],"risk":[24],"scores":[25],"for":[26,89,155],"predicting":[27,90],"imatinib":[28,157],"treatment":[29,91,131,158],"failure.":[30,159],"Materials":[31],"and":[32,46,55,78,118],"Methods:":[33],"A":[34],"total":[35],"201":[37],"patients":[38],"CML":[40,152],"treated":[41],"between":[42],"January":[43,47],"1,":[44],"2000,":[45],"10,":[48],"2025,":[49],"were":[50,127],"included":[51],"[94":[52],"(46.7%)":[53],"female":[54],"107":[56],"(53.3%)":[57],"male;":[58],"mean":[59],"age":[60],"47":[61],"\u00b1":[62],"16":[63],"years;":[64],"median":[65],"follow-up":[66],"107.0":[67],"months":[68],"(minimum-maximum)":[69],"(6.4-359.6)].":[70],"Results:":[71],"Compared":[72],"Sokal,":[75],"Hasford,":[76],"EUTOS,":[77],"ELTS":[79],"scores,":[80],"demonstrated":[84],"highest":[86,95],"discriminative":[87],"ability":[88],"failure,":[92],"5-year":[96],"time-dependent":[97],"AUC":[98],"(0.775,":[99],"95%":[100,114,121],"CI":[101,115,122],"0.700-0.849).":[102],"In":[103,139],"competing-risk":[104],"regression":[105],"analysis,":[106],"both":[107],"intermediate-risk":[109],"(subdistribution":[110],"hazard":[111],"ratio":[112],"(SHR)=5.36,":[113],"2.19-13.10;":[116],"p<0.001)":[117,124],"high-risk":[119],"(SHR=11.40,":[120],"4.49-29.00;":[123],"groups":[126],"significantly":[128],"associated":[129],"failure":[132],"compared":[133],"low-risk":[136],"group.":[137],"Conclusion:":[138],"conclusion,":[140],"showed":[144],"better":[145],"than":[148],"four":[151],"scoring":[153],"systems":[154],"first-line":[156]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-28T00:00:00"}